FDA Warns Consumer Genomics Firms, Illumina on Selling Unapproved Dx Products

The letters are the FDA's latest efforts to assert that DTC genomics service providers are using devices that are actually diagnostic products that require marketing clearance.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.